DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Piramal Pharma Limited — Analyst/Investor Meet Para A-XBRL

NSE 45 min ago·16 Oct 2026, 7:03 am

Piramal Pharma

Piramal Pharma Limited has informed stock exchanges about an upcoming meeting with analysts and institutional investors. This event is scheduled to cover the company's financial performance and strategic outlook for the upcoming period.

For investors, such meetings are important as they provide a platform for management to discuss business trends, operational strategies, and future growth plans. This information can help retail investors understand the company's direction and assess its potential in the market.

Investors should watch for any updates on product pipelines, regulatory approvals, or management commentary on market conditions during the session. Following the event, any key takeaways or guidance provided by the company will be crucial for evaluating the stock's near-term prospects.